Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2003-06-30
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Menstrual-phase-dependent Differences in Response to Sleep Loss
NCT05381532
Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism
NCT02171273
The Effects of Night Shift Work on Health Across the Menstrual Cycle
NCT06683248
Harnessing Sleep/Circadian Rhythm Data as a Biomarker to Mitigate Health Risks
NCT03843762
Menopausal Sleep Fragmentation and Body Fat Gain
NCT03047330
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Luteal
Disrupting or changing the timing or the duration of sleep
Disrupting or changing the timing or the duration of sleep
Follicular
Disrupting or changing the timing or the duration of sleep
Disrupting or changing the timing or the duration of sleep
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Disrupting or changing the timing or the duration of sleep
Disrupting or changing the timing or the duration of sleep
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular menstrual cycles
Exclusion Criteria
18 Years
30 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brigham & Women's Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth B Klerman, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital
Janet E Hall, MD
Role: STUDY_DIRECTOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH R01-HD40291
Identifier Type: -
Identifier Source: secondary_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.